Search

1. Variation in use of anti-SARS-CoV-2 monoclonal antibody therapies by social vulnerability and urbanicity

Author(s):

Kolbe, Allison, author

Publication:

Washington, DC : Office of the Assistant Secretary for Planning and Evaluation, Office of Science & Data Policy, December 2021

Subject(s):

Antibodies, Monoclonal, Humanized -- therapeutic use
COVID-19 Drug Treatment
Healthcare Disparities
Social Vulnerability
Urban Population
Vulnerable Populations
United States

2. Demographic characteristics of adults receiving COVID-19 booster vaccinations

Author(s):

Marus, Jessica, author
Holtkamp, Nick, author
Kolbe, Allison, author
Beleche, Trinidad, author

Publication:

Washington, D.C. : Office of the Assistant Secretary for Planning and Evaluation, Office of Science & Data Policy, March 2022

Subject(s):

COVID-19 Vaccines
Demography
Immunization, Secondary -- statistics & numerical data
Vaccination -- statistics & numerical data
United States

3. Parents’ intentions to vaccinate children for COVID-19 by child age: sociodemographic factors and reasons for hesitancy

Author(s):

Kolbe, Allison, author
Beleche, Trinidad, author
Ross, Tamia, author
Marus, Jessica, author

Publication:

Washington, D.C. : Office of the Assistant Secretary for Planning and Evaluation, Office of Science & Data Policy, February 2022

Subject(s):

Adolescent
Child
COVID-19 Vaccines -- therapeutic use
Intention
Parents
Vaccination Hesitancy -- statistics & numerical data
United States

4. COVID-19 vaccination associated with reductions in COVID-19 mortality and morbidity in the United States, and an approach to valuing these benefits

Author(s):

Holtkamp, Nicholas, author
Kolbe, Allison, author
Beleche, Trinidad, author

Publication:

Washington, D.C. : Office of the Assistant Secretary for Planning and Evaluation, December 2021

Subject(s):

COVID-19 -- epidemiology
COVID-19 -- mortality
COVID-19 Vaccines -- economics
Hospitalization -- statistics & numerical data
Insurance Coverage
Morbidity
United States